Vycor Medical, Inc.

Equities

VYCO

US92921M2035

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 03:52:19 2024-04-09 pm EDT			5-day change	1st Jan Change
0.084 ^USD	0.00%		0.00%	+8.81%

Apr. 16	Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Vycor Medical, Inc. Auditor Raises 'Going Concern' Doubt

April 12, 2022

Vycor Medical, Inc. filed its 10-K on Apr 13, 2022 for the period ending Dec 31, 2021. In this report its auditor, Prager Metis CPAs, LLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Latest news about Vycor Medical, Inc.

Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Vycor Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-14	CI
Vycor Medical, Inc. Auditor Raises 'Going Concern' Doubt	23-04-13	CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Vycor Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-10	CI
Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-13	CI
Vycor Medical, Inc. Auditor Raises 'Going Concern' Doubt	22-04-12	CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Vycor Medical, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-14	CI
Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-31	CI
Vycor Medical, Inc. Announces Board Resignations	21-03-22	CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-13	CI
Vycor Medical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-17	CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-12	CI
Vycor Medical, Inc. Announces Resignation of Oscar Bronsther as Director, Effective July 1, 2020	20-03-27	CI
Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-27	CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-12	CI
Vycor Medical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-09	CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-13	CI
Vycor Medical Inc. Reports Consolidated Earnings Results for the Year Ended December 31, 2018	19-03-29	CI

Chart Vycor Medical, Inc.

Duration

Period

More charts

Company Profile

Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company designs, develops and markets neurological medical devices and therapies. The Company operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment designs, develops and markets medical devices for use in neurosurgery. The NovaVision segment provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. Vycor Medical's product Vycor Medical's ViewSite Brain Access System (VBAS) is a next generation retraction and access system. Vycor Medical focuses on brain and cervical surgical access systems for sale to hospitals and medical professionals. NovaVision's products include Vision Restoration Therapy (VRT), NeuroEyeCoach and Neuro-Eye Therapy (NeEt). The Company operates in the United States and Europe.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
VYCOR MEDICAL, INC.	+8.81%	2.74M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution